Daiichi Sankyo and Ranbaxy launch hybrid business in Brazil to expand business of both companies
- Details
- Category: Daiichi Sankyo
![Daiichi Sankyo Daiichi Sankyo](/images/stories/logo/daiichi-sankyo.gif)
Roche Group posts strong sales growth in the first quarter
- Details
- Category: Roche
![Roche Roche](/images/stories/logo/roche.gif)
Lundbeck announces positive results for Brintellix™ (vortioxetine)
- Details
- Category: Lundbeck
![Lundbeck Lundbeck](/images/stories/logo/lundbeck.gif)
Astellas and Ambrx initiate collaboration for discovery and development of antibody drug conjugates for oncology
- Details
- Category: Business
![Astellas](/images/stories/logo/astellas.gif)
MedImmune, AstraZeneca's biologics unit, acquires AlphaCore Pharma
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](/images/stories/logo/astrazeneca.gif)
Supreme Court denial of Glivec patent clarifies limited intellectual property protection and discourages future innovation in India
- Details
- Category: Novartis
![Novartis Novartis](/images/stories/logo/novartis_b.gif)
FDA perspective published in the New England Journal of Medicine reinforces safety of Pradaxa® (dabigatran etexilate)
- Details
- Category: Boehringer Ingelheim
![Boehringer Ingelheim Boehringer Ingelheim](/images/stories/logo/boehringeringelheim.gif)
More Pharma News ...
- Lundbeck and Otsuka further expand their alliance and enter into collaboration
- AstraZeneca settles litigation over CRESTOR patent
- Gilenya® significantly reduced rate of brain volume loss across three large Phase III studies
- Amgen announces top-line results of phase 3 talimogene laherparepvec trial in melanoma
- $500,000 endowment gift from the GlaxoSmithKline Foundation
- AstraZeneca to establish strategic R&D centres
- Merck announces collaboration with nordic Bioscience for Sprifermin